Strategies for care of patients with gastrointestinal stromal tumor or soft tissue sarcoma during COVID-19 pandemic: A guide for surgical oncologists

Dario Callegaro, Chandrajit P. Raut, Emily Z. Keung, Teresa Kim, Cecile Le Pechoux, Javier Martin-Broto, Alessandro Gronchi, Carol Swallow, Rebecca Gladdy

Research output: Contribution to journalReview articlepeer-review

6 Scopus citations

Abstract

The coronavirus disease-2019 (COVID-19) pandemic is deeply impacting the accessibility of cancer patients to surgery. In resource-limited conditions, the standard of care might not be deliverable, but evidence to support alternative management strategies often exists. By revisiting available treatment options, this review provides surgical oncologists with an evidence-based framework for treating patients with gastrointestinal stromal tumor, extremity/truncal soft tissue sarcoma, and retroperitoneal sarcoma to rapidly adapt their decision-making to the constant evolution of the COVID-19 pandemic.

Original languageEnglish (US)
Pages (from-to)12-23
Number of pages12
JournalJournal of surgical oncology
Volume123
Issue number1
DOIs
StatePublished - Jan 2021

Keywords

  • COVID-19
  • gastrointestinal stromal tumor
  • retroperitoneal sarcoma
  • sarcoma
  • soft tissue sarcoma

ASJC Scopus subject areas

  • Surgery
  • Oncology

Fingerprint

Dive into the research topics of 'Strategies for care of patients with gastrointestinal stromal tumor or soft tissue sarcoma during COVID-19 pandemic: A guide for surgical oncologists'. Together they form a unique fingerprint.

Cite this